AbTis
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
A-815 Suwon Venture Valley Ii 142-10 San...Website
www.abtis.co.krRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About AbTis
AbTis is a biotechnology company specializing in the development of antibody-drug conjugates (ADCs) through its proprietary linker conjugation technology, AbClick. Established in 2016, the company focuses on building a diverse pipeline of bioconjugate assets and forming strategic global partnerships to enhance therapeutic potential. AbTis aims to provide innovative and efficient solutions for the ADC industry, collaborating with contract development and manufacturing organizations to accelerate the development of next-generation therapeutics. Their target clients include pharmaceutical companies and research organizations seeking advanced ADC technologies and solutions.Explore more
AbTis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AbTis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if AbTis had a recent Job posting/layoffs
Funding: Get notified immidiatlly once AbTis has new funding data
Check out if AbTis is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at AbTis
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on AbTis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if AbTis has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when AbTis launches new products
AbTis, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at AbTis
Find more new buyers
Company Profile Activity
Activity Insights
AbTis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AbTis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AbTis.
AbTis News & Media
WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates
SHANGHAI and SEOUL, South Korea, July 7, 2022 /PRNewswire/ -- WuXi XDC, a global leading CRDMO (Contract Research, Development and Manufacturing Organization) dedicated to end-to-end bioconjugates services, and AbTis, a Korean biotechnology company dedicated to the development of antibody...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AbTis
Sign Up For FreeTo access detailed company insights
AbTis is a biotechnology company specializing in the development of antibody-drug conjugates (ADCs) through its proprietary linker conjugation technology, AbClick. Established in 2016, the company focuses on building a diverse pipeline of bioconjugate assets and forming strategic global partnerships to enhance therapeutic potential. AbTis aims to p... Read More
